Ultrastructural and Echocardiographic Assessment of Chronic Doxorubicin-Induced Cardiotoxicity in Rats

AUTHORS

H. Babaei 1 , 2 , N. Razmaraii 1 , 3 , * , Gh. Assadnassab 4 , A. Mohajjel Nayebi 2 , Y. Azarmi 2 , D. Mohammadnejad 1 , A. Azami 1 , 5

1 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

2 School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

3 Department of Cellular and Molecular Biotechnology, Razi Vaccine and Research Institute, Agricultural Research, Education, and Extension Organization, Karaj, Iran

4 Department of Veterinary Clinical Sciences, Tabriz Branch, Islamic Azad University, Tabriz, Iran

5 Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran

How to Cite: Babaei H, Razmaraii N, Assadnassab G, Mohajjel Nayebi A, Azarmi Y, et al. Ultrastructural and Echocardiographic Assessment of Chronic Doxorubicin-Induced Cardiotoxicity in Rats, Arch Razi Inst. 2020 ; 75(1):e103439. doi: 10.22092/ari.2019.116862.1177.

ARTICLE INFORMATION

Archives of Razi Institute: 75 (1); 55-62
Published Online: March 01, 2020
Article Type: Research Article
Received: April 06, 2020
Accepted: March 13, 2019
Crossmark
Crossmark
CHECKING
READ FULL TEXT

Abstract

Doxorubicin (DOX) is one of the secondary metabolites of Streptomyces peucetius var. caesius. It is a common and effective chemotherapeutic agent used for the treatment of different diseases, including lymphoma, leukemia, breast cancer, and solid tumors. However, this medicine causes cardiotoxic side effects, which limit its clinical application. The present study examined the cardiomyopathy induced by DOX via echocardiography and transmission electron microscopy (TEM). The main objective was to evaluate the capacity of echocardiography and TEM as diagnostic tools for DOX-induced cardiotoxicity. Moreover, the correlation between intracellular and functional changes due to cardiotoxicity was assessed in a rat model. Cardiomyopathy was induced in rats by two cumulative doses of DOX. Group I received DOX 12 [i.e., 12 mg/kg, intraperitoneal (IP)] and group II received DOX 15 (i.e., 15 mg/kg, IP) in six equal doses over two weeks. Group III as the control (Ctrl) group received normal saline as a vehicle. Mortality during the study was only observed in the DOX 15 group. The echocardiographic assessments revealed significant changes in ejection fraction, fractional shortening, and heart rate in the groups which received DOX. In addition, severe cardiac arrhythmia was evident in DOX-treated groups. Remarkable adverse effects, such as moderately degenerated cells and inflated mitochondria were observed in the TEM analysis of rat hearts in the DOX groups. The present study indicated that rat models are suitable for investigating DOX-induced cardiomyopathy, especially at the dose of 12 mg/kg. Furthermore, echocardiography and TEM examinations were found to be valuable methods for the determination of cardiotoxicity in rats due to DOX. 

© 2020, Archives of Razi Institute. Razi Vaccine and Serum Research Institute.

Fulltext

COMMENTS

LEAVE A COMMENT HERE: